Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 04/09/2021
Closing price: 268.17
|Support price level:||$258.18|
|Resistance price level:||$289.24|
|Relative strength index (14-day RSI)||51.3|
- With a -15.4 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- Down 3.8 percent, BIIB is one of this week's biggest decliners.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 43.7%.
- Volatility is forecast to fall over the next month.
- Price crossed below 50-day moving average this week - a bearish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 11.9% in the next week.
- 25.2% in the next month.
- 108.4% in the next year.